Department of Pediatrics, Boston Children's Hospital, Boston, MA.
Department of Cardiology, Boston Children's Hospital, Boston, MA.
Pediatr Crit Care Med. 2020 Jan;21(1):75-81. doi: 10.1097/PCC.0000000000002073.
To quantify and identify factors associated with bleeding events during pediatric extracorporeal membrane oxygenation.
Retrospective cohort study with primary outcome of bleeding days on extracorporeal membrane oxygenation.
Single tertiary care children's hospital.
One-hundred twenty-two children supported with extracorporeal membrane oxygenation for greater than 12 hours during January 2015 through December 2016.
Bleeding days were identified if mediastinal or cannula site exploration, activated factor VII administration, gastrointestinal, pulmonary, or intracranial hemorrhages occurred. Logistic regression was used to assess factors associated with bleeding days.
Study population was identified from institutional extracorporeal membrane oxygenation database. Clinical, laboratory, and survival data were obtained from medical records. Only data from patients' first extracorporeal membrane oxygenation run were used. One-hundred twenty-two patients with median age of 17 weeks (interquartile range, 1-148 wk) were analyzed. Congenital heart disease (n = 56, 46%) was the most common diagnosis. Bleeding days comprised 179 (16%) of the 1,121 observed extracorporeal membrane oxygenation-patient-days. By extracorporeal membrane oxygenation day 4, 50% of users had experienced a bleeding day. Central rather than peripheral cannulation (odds ratio, 2.58; 95% CI, 1.47-4.52; p < 0.001), older age (odds ratio, 1.31 per increased week; 95% CI, 1.14-1.52; p < 0.001), higher lactate (odds ratio, 1.08 per 1 mmol/L increase; 95% CI, 1.05-1.12; p < 0.001), and lower platelets (odds ratio, 0.87 per 25,000 cell/μL increase; 95% CI, 0.77-0.99; p = 0.005) were associated with bleeding days. Patients who experienced more frequent bleeding (> 75th percentile) had fewer ventilator-free and hospital-free days in the 60 days after cannulation (0 vs 31; p = 0.002 and 0 vs 0; p = 0.008) and higher in-hospital mortality (68 vs 34%; p < 0.001).
Central cannulation, older age, low platelets, and high lactate are associated with bleeding days during pediatric extracorporeal membrane oxygenation. Patients who bleed more frequently during extracorporeal membrane oxygenation have higher in-hospital mortality, longer technological dependence, and reduced hospital-free days.
量化并确定与儿科体外膜肺氧合期间出血事件相关的因素。
以体外膜肺氧合期间出血天数为主要结局的回顾性队列研究。
单中心三级儿童保健医院。
2015 年 1 月至 2016 年 12 月期间,122 名接受体外膜肺氧合治疗超过 12 小时的儿童。
如果发生纵隔或导管部位探查、使用活化因子 VII 治疗、胃肠道、肺部或颅内出血,则确定出血天数。使用逻辑回归评估与出血天数相关的因素。
从机构体外膜肺氧合数据库中确定研究人群。从病历中获取临床、实验室和生存数据。仅使用患者第一次体外膜肺氧合运行的数据。分析了 122 名中位年龄为 17 周(四分位间距,1-148 周)的患者。先天性心脏病(n=56,46%)是最常见的诊断。出血天数占 1121 个观察到的体外膜肺氧合-患者-天数中的 179 天(16%)。到体外膜肺氧合第 4 天,50%的使用者经历了出血天数。中央而非外周置管(比值比,2.58;95%置信区间,1.47-4.52;p<0.001)、年龄较大(比值比,每增加 1 周增加 1.31;95%置信区间,1.14-1.52;p<0.001)、较高的乳酸(比值比,每增加 1 mmol/L 增加 1.08;95%置信区间,1.05-1.12;p<0.001)和较低的血小板(比值比,每增加 25,000 个细胞/μL 降低 0.87;95%置信区间,0.77-0.99;p=0.005)与出血天数相关。在置管后 60 天内经历更频繁出血(>75 百分位数)的患者呼吸机脱机和住院天数更少(0 与 31;p=0.002 和 0 与 0;p=0.008),住院死亡率更高(68 与 34%;p<0.001)。
儿科体外膜肺氧合期间中央置管、年龄较大、血小板较低和乳酸较高与出血天数有关。体外膜肺氧合期间出血更频繁的患者院内死亡率更高,技术依赖性更长,住院天数减少。